Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2 years.

Source:http://linkedlifedata.com/resource/pubmed/id/20505533

Download in:

View as

General Info

PMID
20505533